MD Anderson Events

Pediatrics Research Seminar Series: Inflammatory Mediators and Epigenetic Effects on Colorectal Cancer Progression

Date: 2/7/12, 9am to 10am
Time: 2/7/12, 9am to 10am
Location: Smith Research Building, Conference SRB1.122
Format: Seminar/Conference
Facilitator: Vidya Gopalakrishnan, PhD
Speaker Bio: Dr. DuBois is provost and executive vice president of MD Anderson Cancer Center. He is also a professor of cancer biology and cancer medicine at the institution. He obtained his medical degree from The University of Texas Health Science Center at San Antonio. His research goals are to advance the understanding, diagnosis, treatment and prevention of colorectal cancer. His lab was among the first to recognize that cyclooxygenase (COX) plays a key role in the formation of adenomatous polyps and colorectal cancer and to appreciate that prostaglandin E2 (PGE2) exhibits most of the cancer-promoting activity of the PGs. These exciting discoveries led to successful clinical translational studies applying the use of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of high-risk colorectal cancer patients. DuBois provides executive leadership for MD Anderson’s research program, which is considered one of the most productive undertakings in the world aimed solely at cancer. MD Anderson ranks first in the amount of grant funds given by the National Cancer Institute (NCI).
Contact: Samuel Riley - (713) 563-5394 - sriley@mdanderson.org

Add event to my calendar